Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PRWCXT. Rowe Price Capital Appreciation Fund | $37.72 | +0.53% | $38.9B | — |
| MDIJXMFS International Diversification Fund | $30.10 | +0.84% | $45.0B | — |
| MFEIXMFS Growth Fund | $201.43 | +1.90% | $42.4B | — |
| PREIXT. Rowe Price Equity Index 500 Fund | $193.05 | +1.17% | $40.7B | — |
| RBHEXAmerican Funds 2050 Target Date Retirement Fund |
No one on the platform currently holds PRWCX.
No tracked institution reports a position in PRWCX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-17 | $3.1511 | 2025-12-18 |
| 2024-12-18 | $3.5922 | 2024-12-19 |
| 2023-12-19 | $1.4075 | 2023-12-20 |
No one on the platform has traded PRWCX yet.
| $25.27 |
| +1.08% |
| $43.9B |
| — |
| RRMGXT. Rowe Price Mid-Cap Growth Fund | $87.51 | +0.92% | $29.6B | — |
| VGHCXVanguard Health Care Fund Investor Shares | $206.97 | +0.57% | $37.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.